Skip to main content
All lobbying filings

EMD SERONO, INC.

EMD SERONO, INC. filed a Q2 report for EMD SERONO INC on July 21, 2025.

Lobbying for EMD SERONO INC

All filings by EMD SERONO, INC. · Everything EMD SERONO INC has reported

 Filing · LD-2 quarterly report Q2 report
Reporting period
2nd Quarter 2025
Apr 1 - June 30 · Posted Jul 21, 2025
Expenses
$910,000
What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
District of Columbia

Official filing document

 Government bodies contacted 6

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 9
Health Issues

H.R. 1: One Big Beautiful Bill Act; provisions related to Title VII, Subtitle B H.R. 946: Orphan CURES Act; all provisions H.R. 2214: DRUG Act; all provisions S. 864: HELP Copays Act; all provisions S. 882: Patients Before Middlemen Act; all provisions S. 891: Bipartisan Health Care Act; provisions related to Titles I, II, VIII, and IX S. 1862: Orphan CURES Act; all provisions Executive Order: Expanding Access to In Vitro Fertilization; all provisions of the order General discussions related to Pharmacy Benefit Manager policy issues General discussions related to Healthcare supply chain policy issues General discussions related to Drug cost and pricing policy issues General discussions related to caregiving support and awareness policy issues

Medicare/Medicaid

H.R. 1: One Big Beautiful Bill Act; relating to Title VII, Subtitle B H.R. 1492: To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.; all provisions S. 832: EPIC Act of 2025; all provisions S. 891: Bipartisan Health Care Act; provisions related to Titles I, II, VIII, and IX General discussions related to Drug cost and pricing policy issues

Pharmacy

General discussions related to Drug cost and pricing policy issues General discussions related to Healthcare supply chain policy issues General discussions related to 340B Drug Pricing Program policy issues

Taxation/Internal Revenue Code

H.R. 1: One Big Beautiful Bill Act; provisions related to Sec. 899

Veterans

H.R. 220: Veterans Infertility Treatment Act of 2025; all provisions

Defense

Discussions related to Military access to infertility care

Copyright/Patent/Trademark

General discussions related to Biopharmaceutical innovation and patent policy issues

Trade (domestic/foreign)

Discussions related to tariffs

Environment/Superfund

Discussions related to the Environmental Protection Agency's (EPA) Low Volume Exemption (LVE) Process

 Bills named in this filing 10
  • H.R. 1
    One Big Beautiful Bill Act
  • H.R. 946
    ORPHAN Cures Act
  • H.R. 2214
    DRUG Act
  • S. 864
    HELP Copays Act
  • S. 882
    Patients Before Middlemen Act
  • S. 891
    Bipartisan Health Care Act
  • S. 1862
    ORPHAN Cures Act
  • H.R. 1492
    To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic can…
  • S. 832
    EPIC Act of 2025
  • H.R. 220
    Veterans Infertility Treatment Act of 2025

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem